AMPLIFICATION OF THE C-ERB B-2 ONCOGENE AND PROGNOSIS OF BREAST ADENOCARCINOMA
- 1 February 1990
- journal article
- research article
- Vol. 114 (2) , 160-163
Abstract
Fifty patients with typical infiltrating ductal adenocarcinoma of the breast were studied for amplification of the c-erb B-2 (neu/HER-2) oncogene within the tumor DNA. Amplification, ranging from 4 to greater than 50 copies per cell, was observed in 17 (34%) of the samples. The presence of c-erb B-2 gene amplification was not significantly correlated with patient survival, metastases, recurrence, or overall histologic grade. However, amplification was significantly associated with increased mitotic activity. Also, amplification of c-erb B-2 showed a significantly negative association with both progesterone and estrogen receptor presence. Progesterone receptor presence correlated significantly with survival.This publication has 12 references indexed in Scilit:
- THE HISTOLOGICAL GRADING OF NEOPLASMS1988
- CORRELATION OF C-ERBB-2-GENE AMPLIFICATION AND PROTEIN EXPRESSION IN HUMAN-BREAST CARCINOMA WITH NODAL STATUS AND NUCLEAR GRADING1988
- ASSOCIATION OF MULTIPLE COPIES OF THE C-ERBB-2 ONCOGENE WITH SPREAD OF BREAST-CANCER1987
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- ALTERATIONS TO EITHER C-ERB-2 (NEU)-PROTO-ONCOGENE OR C-MYC-PROTO-ONCOGENE IN BREAST CARCINOMAS CORRELATE WITH POOR SHORT-TERM PROGNOSIS1987
- AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVOThe Lancet, 1986
- A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.Proceedings of the National Academy of Sciences, 1985
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984
- MORPHOMETRIC ANALYSIS OF DIFFERENTIATION IN HUMAN-BREAST CARCINOMA - TUMOR GRADING1983
- HISTOPATHOLOGICAL MALIGNANCY GRADING AND FAMILIALITY IN AN UNSELECTED SERIES OF 1303 WOMEN WITH BREAST-CARCINOMA1982